| Elaine K Keating, | |
|
3947 Pippin Ln, Lafayette, IN 47905-4438 | |
| (765) 414-9999 | |
| Not Available |
| Full Name | Elaine K Keating |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3947 Pippin Ln, Lafayette, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275951790 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22005878A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elaine K Keating, 3947 Pippin Ln, Lafayette, IN 47905-4438 Ph: (765) 414-9999 | Elaine K Keating, 3947 Pippin Ln, Lafayette, IN 47905-4438 Ph: (765) 414-9999 |
News Archive
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
​Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years.
As the State of Florida grapples with a budget shortfall that has crippled its AIDS Drug Assistance Program (ADAP) and forced the state to potentially disenroll 350 Florida patients already on ADAP as well as place nearly 2,400 low-income Floridians on waiting lists to access lifesaving medications, AIDS Healthcare Foundation (AHF) has proposed an innovative plan to help state health officials and displaced HIV/AIDS patients bridge the transition to private patient assistance programs run by the major pharmaceutical companies.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
› Verified 3 days ago
Hailey C Small, MS CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 | |
Lauren Colbert, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Executive Dr, Lafayette, IN 47905 Phone: 765-446-8300 Fax: 765-446-8301 | |
Ms. Gretchen Kay Foster, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Windy Hill Dr, Lafayette, IN 47905 Phone: 765-477-7791 Fax: 765-474-2986 | |
Heather Lavoine, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2303 Flowering Crab Dr W, Lafayette, IN 47905 Phone: 812-223-2250 | |
Alana Cowan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Executive Dr Ste 5, Lafayette, IN 47905 Phone: 765-446-8300 | |
Monica Snyder, MS Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7625 | |
Taylor Weaver-rosamilia, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3700 Rome Dr, Lafayette, IN 47905 Phone: 765-448-4220 |